申请人:Aktiebolaget Astra
公开号:US05585378A1
公开(公告)日:1996-12-17
The present invention relates to an oxindole compound having the formula 5-cyclohexyl-1,3-dihydro-1-[2-[4-(phenylmethyl)-1-piperazinyl]ethyl]-2H-in dol-2-one for the prevention or treatment of cognitive dysfunctions.
本发明涉及一种具有下列结构式的氧吲哚化合物,用于预防或治疗认知功能障碍:5-环己基-1,3-二氢-1-[2-[4-(苯甲基)-1-哌嗪基]乙基]-2H-吲哚-2-酮。